selected publications
-
academic article
- . ¿CGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors.. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AME. 18345-18350. 2020
- A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration. JOURNAL OF MEDICINAL CHEMISTRY. 2372-2390. 2020
- Improving a Natural Compound: Design of Innovative Neurocosmeceuticals for Sensitive Skin. IFSCC MAGAZINE. 37-44. 2020
- Moduladores del termorreceptor TRPV1 desactivables metabólicamente en la farmacología. ACTUALIDAD EN FARMACOLOGIA Y TERAPEUTICA. 162-172. 2020
- A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.. JOURNAL OF MEDICINAL CHEMISTRY. 1-12. 2019
- Effect of a novel TRPV1 antagonist on capsaicin nociceptors. FRONTIERS IN CELLULAR NEUROSCIENCE. 1-4. 2018
- Targeting transient receptor potential vanilloid 1 channel (TRPV1) softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders. JOURNAL OF MEDICINAL CHEMISTRY. 4436-4455. 2018
- 1. Calcium Entry Through Thermosensory Channels. . ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 265-304. 2016
- Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors.. FRONTIERS IN PHARMACOLOGY. 1-12. 2016
- Neurotrophins, endocannbinoids and thermo-transient receptor potential: a threesome in pain signalling. EUROPEAN JOURNAL OF NEUROSCIENCE. 353-362. 2014
- aCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 18250-18256. 2014
- Targeting protein-protein interactions to rescue ¿f508-cftr: a novel corrector approach to treat cystic fibrosis.. EMBO MOLECULAR MEDICINE. 1462-1464. 2013
- In silico-based direct evolution of peptides and peptidomimetics in drug discovery. CURRENT TOPICS IN PHARMACOLOGY. 35-55. 2012
- New strategies to develop novel pain therapies: Addressing thermoreceptors from different points of view.. PHARMACEUTICALS. 16-48. 2012
- TNF / IL-17 INTERPLAY INDUCES S100A8, IL-1BETA, AND MMPS, AND DRIVES IRREVERSIBLE CARTILAGE DESTRUCTION IN VIVO: RATIONALE FOR COMBINATION TREATMENT DURING ARTHRITIS.. ARTH RHEUM/AR C RES. 2329-2339. 2011
- The role of the transient receptor potential vanilloid 1 (TRPV1) in inflammation and sepsis.. JOURNAL OF INFLAMMATION RESEARCH. 67-81. 2011
-
congress communication
- Diseño in silico y validación de moduladores del canal iónico TRAAK 2020
- In vitro characterization of a TRPV1 soft antagonist. 2019
- In vitro characterization of a TRPV1 soft antagonist. 2019
- A capsaicin-based TRPV1 soft antagonist as an anti-pruritic drug candidate 2019
- A capsaicin-based TRPV1 soft antagonist as an anti-pruritic drug candidate. 2019
- Improving a Natural Compound: Design of innovative neurocosmeceuticals for sensitive skin 2019
- In vitro characterization of a TRPV1 soft antagonist. 2019
- In vitro characterization of a TRPV1 soft antagonist. 2019
- Targeting TRPV1 softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders. 148-149. 2018
- Targeting TRPV1 softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders 2018
- TRPducins: a novel paradigm to modulate ion channel signalling 2012